192 related articles for article (PubMed ID: 11592788)
1. 1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue.
Aschenbrenner JK; Sollinger HW; Becker BN; Hullett DA
J Surg Res; 2001 Oct; 100(2):171-5. PubMed ID: 11592788
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements.
Subramaniam N; Leong GM; Cock TA; Flanagan JL; Fong C; Eisman JA; Kouzmenko AP
J Biol Chem; 2001 May; 276(19):15741-6. PubMed ID: 11278818
[TBL] [Abstract][Full Text] [Related]
3. A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Ito I; Waku T; Aoki M; Abe R; Nagai Y; Watanabe T; Nakajima Y; Ohkido I; Yokoyama K; Miyachi H; Shimizu T; Murayama A; Kishimoto H; Nagasawa K; Yanagisawa J
J Clin Invest; 2013 Nov; 123(11):4579-94. PubMed ID: 24135137
[TBL] [Abstract][Full Text] [Related]
4. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins.
Yanagi Y; Suzawa M; Kawabata M; Miyazono K; Yanagisawa J; Kato S
J Biol Chem; 1999 May; 274(19):12971-4. PubMed ID: 10224044
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta-induced dissociation between vitamin D receptor level and 1,25-dihydroxyvitamin D3 action in osteoblast-like cells.
Staal A; Birkenhäger JC; Pols HA; Buurman CJ; Vink-van Wijngaarden T; Kleinekoort WM; van den Bemd GJ; van Leeuwen JP
Bone Miner; 1994 Jul; 26(1):27-42. PubMed ID: 7950503
[TBL] [Abstract][Full Text] [Related]
8. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.
Yanagisawa J; Yanagi Y; Masuhiro Y; Suzawa M; Watanabe M; Kashiwagi K; Toriyabe T; Kawabata M; Miyazono K; Kato S
Science; 1999 Feb; 283(5406):1317-21. PubMed ID: 10037600
[TBL] [Abstract][Full Text] [Related]
9. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.
Fukasawa H; Yamamoto T; Suzuki H; Togawa A; Ohashi N; Fujigaki Y; Uchida C; Aoki M; Hosono M; Kitagawa M; Hishida A
Kidney Int; 2004 Jan; 65(1):63-74. PubMed ID: 14675037
[TBL] [Abstract][Full Text] [Related]
10. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
12. [Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts].
Pei Y; Zhou XY; Meng XW; Xia WB; Xing XP; Liu HC; Hu YY
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1084-8. PubMed ID: 12899784
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
14. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling.
Zhao Y; Geverd DA
Biochem Biophys Res Commun; 2002 Jun; 294(2):319-23. PubMed ID: 12051713
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
17. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
